Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system

被引:0
作者
Singh, Robel [1 ]
Soni, Pawan [2 ]
Kumar, Davinder [1 ]
Aggarwal, Navidha [3 ]
Chopra, Hitesh [4 ]
Kumar, Virender [1 ]
机构
[1] Univ Hlth Sci Rohtak, Coll Pharm, PGIMS, Pt BD Sharma, Rohtak 124001, India
[2] Govt India, Minist Hlth & Family Welf, Indian Pharmacopoeia Commiss, Ghaziabad, India
[3] Maharishi Markandeshwar Deemed Univ, MM Coll Pharm, Mullana 133207, Ambala, India
[4] Saveetha Inst Med & Tech Sci, Saveetha Sch Engn, Dept Biosci, Chennai 602105, Tamil Nadu, India
关键词
alopecia areata; auto-immune disorder; clobetasol propionate; exuberate; Injectable modalities; nanoparticulate drug delivery; nonscarring; systemic illness; CLOBETASOL PROPIONATE 0.05-PERCENT; TOPICAL MINOXIDIL; LIPID NANOPARTICLES; DRUG-DELIVERY; HAIR FOLLICLE; DERMAL DELIVERY; DOUBLE-BLIND; THERAPY; PREVALENCE; EFFICACY;
D O I
10.4155/tde-2023-0071
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Alopecia areata (AA) is a kind of alopecia that affects hair follicles and nails. It typically comes with round patches and is a type of nonscarring hair loss. Various therapies are accessible for the management and treatment of AA, including topical, systemic and injectable modalities. It is a very complex type of autoimmune disease and is identified as round patches of hair loss and may occur at any age. This review paper highlights the epidemiology, clinical features, pathogenesis and new treatment options for AA, with a specific emphasis on nanoparticulate drug-delivery systems. By exploring these innovative treatment approaches, researchers aim to enhance the effectiveness and targeted delivery of therapeutic agents, ultimately improving outcomes for individuals living with AA.
引用
收藏
页码:193 / 210
页数:18
相关论文
共 23 条
  • [1] Systemic treatments for alopecia areata: A systematic review
    Lai, Vivien Wai Yun
    Chen, Gang
    Gin, Douglas
    Sinclair, Rodney
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (01) : E1 - E13
  • [2] Current and future treatments of alopecia areata and trichotillomania in children
    Iorizzo, Matilde
    Oranje, Arnold P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (13) : 1767 - 1773
  • [3] Treatments for alopecia areata: A systematic review and network meta-analysis
    Fukumoto, Takeshi
    Fukumoto, Rie
    Magno, Elizabeth
    Oka, Masahiro
    Nishigori, Chikako
    Horita, Nobuyuki
    DERMATOLOGIC THERAPY, 2021, 34 (03)
  • [4] Alopecia Areata: Current Treatments and New Directions
    Dahabreh, Dante
    Jung, Seungyeon
    Renert-Yuval, Yael
    Bar, Jonathan
    Del Duca, Ester
    Guttman-Yassky, Emma
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (06) : 895 - 912
  • [5] Epidemiology and burden of alopecia areata: a systematic review
    Fricke, Alexandra C. Villasante
    Miteva, Mariya
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2015, 8 : 397 - 403
  • [6] Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
    Egeberg, Alexander
    Linsell, Louise
    Johansson, Erin
    Durand, Frederick
    Yu, Guanglei
    Vano-Galvan, Sergio
    DERMATOLOGY AND THERAPY, 2023, 13 (12) : 2951 - 2991
  • [7] Epidemiology of alopecia areata in Black patients: A retrospective chart review
    Feaster, Brittany
    McMichael, Amy J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (05) : 1121 - 1123
  • [8] Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
    Paggioli, Isabelle
    Moss, Jeremy
    JOURNAL OF AUTOIMMUNITY, 2022, 133
  • [9] Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis
    Lee, Harrison H.
    Gwillim, Eran
    Patel, Kevin R.
    Hua, Tammy
    Rastogi, Supriya
    Ibler, Erin
    Silverberg, Jonathan, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (03) : 675 - 682
  • [10] Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
    Alexander Egeberg
    Louise Linsell
    Erin Johansson
    Frederick Durand
    Guanglei Yu
    Sergio Vañó-Galván
    Dermatology and Therapy, 2023, 13 : 2951 - 2991